These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Beyond first-line HIV treatment regimens: the current state of antiretroviral regimens, viral load monitoring, and resistance testing in resource-limited settings. Kumarasamy N; Krishnan S Curr Opin HIV AIDS; 2013 Nov; 8(6):586-90. PubMed ID: 24100872 [TBL] [Abstract][Full Text] [Related]
3. Effect on transmission of HIV-1 resistance of timing of implementation of viral load monitoring to determine switches from first to second-line antiretroviral regimens in resource-limited settings. Phillips AN; Pillay D; Garnett G; Bennett D; Vitoria M; Cambiano V; Lundgren J AIDS; 2011 Mar; 25(6):843-50. PubMed ID: 21192233 [TBL] [Abstract][Full Text] [Related]
4. Economic evaluation of monitoring virologic responses to antiretroviral therapy in HIV-infected children in resource-limited settings. Schneider K; Puthanakit T; Kerr S; Law MG; Cooper DA; Donovan B; Phanuphak N; Sirisanthana V; Ananworanich J; Ohata J; Wilson DP AIDS; 2011 Jun; 25(9):1143-51. PubMed ID: 21505319 [TBL] [Abstract][Full Text] [Related]
5. Monitoring of antiretroviral therapy in low-resource settings. Walensky RP; Freedberg KA; Weinstein MC Lancet; 2008 Jul; 372(9635):288; author reply 289. PubMed ID: 18657699 [No Abstract] [Full Text] [Related]
6. Antiretroviral therapy in resource-poor settings: scaling up inequalities? Egger M; Boulle A; Schechter M; Miotti P Int J Epidemiol; 2005 Jun; 34(3):509-12. PubMed ID: 15941732 [No Abstract] [Full Text] [Related]
7. COMMENTARY: understanding the benefits of pediatric anti-retroviral treatment in resource-limited settings. Hetherington S Pediatr Infect Dis J; 2009 Jan; 28(1):41-2. PubMed ID: 19057455 [TBL] [Abstract][Full Text] [Related]
8. Monitoring of antiretroviral therapy in low-resource settings. Bendavid E Lancet; 2008 Jul; 372(9635):288-9; author reply 289. PubMed ID: 18657700 [No Abstract] [Full Text] [Related]
9. Scaling-up antiretroviral treatment in resource-poor countries: prioritization and choices. Korenromp EL; Fakoya A; Viisainen K AIDS; 2011 Mar; 25(6):857-9. PubMed ID: 21412061 [No Abstract] [Full Text] [Related]
10. Antiretroviral therapy in low-resource settings. Cainelli F; Lanzafame M; Vento S Lancet; 2010 Oct; 376(9750):1392. PubMed ID: 20971363 [No Abstract] [Full Text] [Related]
11. Antiretroviral treatment sequencing strategies to overcome HIV type 1 drug resistance in adolescents and adults in low-middle-income countries. De Luca A; Hamers RL; Schapiro JM J Infect Dis; 2013 Jun; 207 Suppl 2():S63-9. PubMed ID: 23687291 [TBL] [Abstract][Full Text] [Related]
12. Antiretroviral treatment in low-resource settings: what has changed in the last 10 years and what needs to change in the coming years? Mehta M; Semitala F; Lynen L; Colebunders R Expert Rev Anti Infect Ther; 2012 Nov; 10(11):1287-96. PubMed ID: 23241186 [TBL] [Abstract][Full Text] [Related]
13. Transmission of drug resistant HIV and its potential impact on mortality and treatment outcomes in resource-limited settings. Cambiano V; Bertagnolio S; Jordan MR; Lundgren JD; Phillips A J Infect Dis; 2013 Jun; 207 Suppl 2():S57-62. PubMed ID: 23687290 [TBL] [Abstract][Full Text] [Related]
14. Initiation of antiretroviral therapy among pregnant women in resource-limited countries: CD4+ cell count response and program retention. Toro PL; Katyal M; Carter RJ; Myer L; El-Sadr WM; Nash D; Abrams EJ; AIDS; 2010 Feb; 24(4):515-24. PubMed ID: 19996939 [TBL] [Abstract][Full Text] [Related]
15. When to switch for antiretroviral treatment failure in resource-limited settings? Vekemans M; John L; Colebunders R AIDS; 2007 May; 21(9):1205-6. PubMed ID: 17502731 [No Abstract] [Full Text] [Related]
16. The cost effectiveness of antiretroviral treatment strategies in resource-limited settings. Bishai D; Colchero A; Durack DT AIDS; 2007 Jun; 21(10):1333-40. PubMed ID: 17545710 [TBL] [Abstract][Full Text] [Related]
17. Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model. Phillips AN; Pillay D; Miners AH; Bennett DE; Gilks CF; Lundgren JD Lancet; 2008 Apr; 371(9622):1443-51. PubMed ID: 18440426 [TBL] [Abstract][Full Text] [Related]
18. Antiretroviral treatment in resource-poor settings: clinical research priorities. Rabkin M; El-Sadr W; Katzenstein DA; Mukherjee J; Masur H; Mugyenyi P; Munderi P; Darbyshire J Lancet; 2002 Nov; 360(9344):1503-5. PubMed ID: 12433534 [No Abstract] [Full Text] [Related]
19. Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis. Boyer S; March L; Kouanfack C; Laborde-Balen G; Marino P; Aghokeng AF; Mpoudi-Ngole E; Koulla-Shiro S; Delaporte E; Carrieri MP; Spire B; Laurent C; Moatti JP; Lancet Infect Dis; 2013 Jul; 13(7):577-86. PubMed ID: 23602084 [TBL] [Abstract][Full Text] [Related]
20. Rationing antiretroviral therapy in Africa--treating too few, too late. Ford N; Mills E; Calmy A N Engl J Med; 2009 Apr; 360(18):1808-10. PubMed ID: 19403900 [No Abstract] [Full Text] [Related] [Next] [New Search]